A multicenter, open, prospective observational study to confirm the clinical efficacy and safety after drug change in patients with degenerative arthritis (spondyloarthritis, knee arthritis) treated with anti-inflammatory analgesics

Yonsei University Health System, Severance Hospital0 个研究点目标入组 800 人开始时间: 待定最近更新: 2022年10月24日

适应症

试验速览

暂无简介。

•1) Patients over 20 years of age who have been diagnosed with spondyloarthritis or gonarthritis among degenerative arthritis prescribed non-selective NSAIDs.
•2) Patients who have not been given Cox2-selective NSAIDs in the treatment of degenerative arthritis within the last 2 weeks.
•3) Patients whose history identifies osteoarthritis with symptoms of the body and whose pain VAS test performed in Visit 2 is greater than 40 mm
•4) A person who voluntarily agrees to participate in this study is able to understand the information provided to him or her and can sign a written consent form at will

•1) A person diagnosed with a clinically significant mental illness and receiving medication.
•2) Patients who scheduled for surgery during the clinical study.
•3) Patients who have a history of allergies to the ingredients that make up this clinical research drug.
•4) A person who is deemed to have a life expectancy of less than six months due to malignant tumors or other serious health conditions affecting his/her life;
•5) Those who participated in another clinical study within 4 weeks before participating in the study
•6) Subjects who are unable to implement the clinical research process specified in the plan
•7) Any other person deemed inappropriate to participate in this clinical study due to the medical opinion of the researcher;

发起方